Questcor Pharmaceuticals, Inc. (QCOR): Here's What Mr. Market Thinks
Many believed that Q1 earnings would be the start of a larger trend higher that reversed the losses seen in shares of Questcor Pharmaceuticals, Inc.
Alexion Pharmaceuticals Inc. (ALXN)
Market is closed
News
- First
- << Previous
- 101 - 110
- Next >>
Alexion Pharmaceuticals, Inc. (ALXN) Soars
As recently as yesterday, 2013 wasn't looking too great for shareholders of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN). The stock was down nearly 11% for the year. Today is a different story.
Sarepta Therapeutics Inc (SRPT), Pharmacyclics, Inc. (PCYC): Are These Billion-Dollar Biotechs Overvalued?
Biotechs with market caps of a billion dollars or more are a dime a dozen. Well, actually, they're more like $12 billion or more a dozen, but you get the point. There are plenty of them.
Eli Lilly & Co. (LLY), WellPoint, Inc. (WLP) & Five Must-Watch Earnings Reports in the Health-Care Sector This Week
If you haven't noticed, it's earnings season once again! Believe it or not, there are times when earnings reports slow down in frequency, but this is certainly not one of those times.
Alexion Pharmaceuticals, Inc. (ALXN), Vertex Pharmaceuticals Incorporated (VRTX): Orphan Drug Biotechs Do It Best
There are many biotech stocks to choose from that have long-lasting value. Each one can potentially have huge value, but there is a group of biotech stocks that focus only on orphan drugs.
Las Vegas Sands Corp. (LVS), EMC Corporation (EMC)...$22.5 Billion Hedge Fund Bullish On These Stocks
Editor's note: There were two errors in our original article: (1) Soliris is approved for both aHUS and PNH (Paroxysmal nocturnal hemoglobinuria).
Alexion Pharmaceuticals, Inc. (ALXN), Align Technology, Inc. (ALGN) & More: Three Surprising Investment Ideas Straight From Obamacare
You can find investment ideas in the strangest places. Take Obamacare, for example. The legislation runs more than 900 pages long and is chock-full of government gobbledy-gook.
Aetna Inc. (AET): Twelve Shocking Truths About Obamacare
There's more in Obamacare than you might think.
Should You Buy Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)?
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) was in 24 hedge funds' portfolio at the end of the fourth quarter of 2012.
Analyst Roundtable: Any Surprises in Amarin Corporation plc (ADR) (AMRN)'s Fourth Quarter?
Motley Fool health care analyst Max Macaluso and Fool contributor Brian Orelli sat down to discuss Amarin Corporation plc (ADR) (NASDAQ:AMRN) , a biotech that recently launched its first drug, Vascepa...
- First
- << Previous
- 101 - 110
- Next >>
Billionaire Hedge Funds
